G MEDICAL ENGAGES US UNDERWRITER TO MANAGE DUAL-LISTING ON NASDAQ
Announcement posted by G Medical Innovations 02 Oct 2018
• Underwriter engaged for the purposes of US Public Offering with intention of dual listing
October 2, 2018 – Sydney, AUSTRALIA - Mobile and e-Health company G Medical Innovations (ASX: GMV) (“G Medical” or the “Company”) has today engaged a New York based Underwriter, to assist in the processes towards a US Public Offering via the NASDAQ Stock Exchange.
The Company will remain listed on the Australian Stock Exchange, and the management of G Medical have engaged an Underwriter who will now proceed with submission of the F-1 Registration Statement with all parties working towards a US listing within the next 4 to 5 months.
G Medical cautions investors that there can be no certainty that the proposed US listing will proceed. Investors should note that the listing is subject to satisfaction of all legal and regulatory requirements with NASDAQ, SEC and ASX, as well as any shareholder approvals that may be required under the ASX Listing Rules.
Shareholders will be updated throughout the process as appropriate, and the amount of capital to be raised will be determined closer to the proposed offering.
The Company will remain listed on the Australian Stock Exchange, and the management of G Medical have engaged an Underwriter who will now proceed with submission of the F-1 Registration Statement with all parties working towards a US listing within the next 4 to 5 months.
G Medical cautions investors that there can be no certainty that the proposed US listing will proceed. Investors should note that the listing is subject to satisfaction of all legal and regulatory requirements with NASDAQ, SEC and ASX, as well as any shareholder approvals that may be required under the ASX Listing Rules.
Shareholders will be updated throughout the process as appropriate, and the amount of capital to be raised will be determined closer to the proposed offering.
-ENDS-
Corporate Advisors
Otsana Capital
108 Outram Street
West Perth WA 6005
Telephone: +61 8 9486 7244
www.otsana.com
Investor Relations
Viriathus Australia
Level 8/525 Flinders Street
Melbourne VIC 3000
Telephone: +61 2 8667 5360
www.viriathus.com
Media Enquiries
Closer Communications
David Wolf
Telephone: + 61 411 111 787
david@closer.com.au
Otsana Capital
108 Outram Street
West Perth WA 6005
Telephone: +61 8 9486 7244
www.otsana.com
Investor Relations
Viriathus Australia
Level 8/525 Flinders Street
Melbourne VIC 3000
Telephone: +61 2 8667 5360
www.viriathus.com
Media Enquiries
Closer Communications
David Wolf
Telephone: + 61 411 111 787
david@closer.com.au
About G Medical Innovations
G Medical (ASX: GMV) was founded in August 2014, aiming to be at the forefront of the digital health revolution, developing the next generation of mobile health (mHealth) technologies. The Company leverages the experience and expertise of its Board to deliver best-in-class solutions to address this global opportunity.
The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.
For more information on G Medical, please visit www.gmedinnovations.com
The Company specialises in innovative next generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams, across numerous verticals and territories.
For more information on G Medical, please visit www.gmedinnovations.com